Stimulation of δ1- and δ2-opioid receptors produces amnesia in mice

European Journal of Pharmacology

Volumn 338, Issue 1, 1997, Pages 1-6

  Ukai, Makoto ^a   Takada, Akio ^a   Sasaki, Yusuke ^b   Kameyama, Tsutomu ^a  

^a MEIJO UNIVERSITY   (Japan)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Opioid receptor; D=Ala2 deltorphin II; Elevated plus maze behavior; Mouse; Passive avoidance learning; Spontaneous alternation performance; D Pen2,L Pen5 enkephalin

Indexed keywords

DELTORPHIN; ENKEPHALIN[2 DEXTRO PENICILLAMINE 5 PENICILLAMINE]; NALTRIBEN; OPIATE ANTAGONIST; OPIATE RECEPTOR; DELTA OPIATE RECEPTOR; ENKEPHALIN; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; OLIGOPEPTIDE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LEARNING; MALE; MEMORY; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; STIMULATION; TRAINING; ANALGESIA; ANIMAL; ANIMAL BEHAVIOR; AVOIDANCE BEHAVIOR; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; DRUG EFFECT; DRUG POTENTIATION; ELECTRIC SHOCK;

AMNESIA; ANALGESIA; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; ELECTROSHOCK; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; MALE; MICE; OLIGOPEPTIDES; RECEPTORS, OPIOID, DELTA;

EID: 0030608932     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01310-1     Document Type: Article

References (37)

1. Beninger R.J., Jhamandas K., Boegman R.J., El-Defrawy S.R. Effects of scopolamine and unilateral lesions of the basal forebrain on T-maze spatial discrimination and alternation in rats. Pharmacol. Biochem. Behav. 24:1986;1353-1360.
2. 2-opioid receptor agonists. Eur. J. Pharmacol. 311:1996;127-132.
3. De Wied D., Bohus B., van Ree J.M., Urban I. Behavioral and electrophysiological effects of peptides related to lipotropin (β-LPH). J. Pharmacol. Exp. Ther. 204:1978;570-580.
4. Dhawan B.N., Cesselin F., Raghubir R., Reisine T., Bradley P.B., Portoghese P.S., Hamon M. International union of pharmacology. XII. Classification of opioid receptors. Pharmacol. Rev. 48:1996;567-592.
5. Erspamer V., Melchiorri P., Falconieri-Erspamer G., Negri L., Corsi R., Sverini C., Barra D., Shimmaco M., Kreil G. Deltorphins: A family of naturally occurring peptides with high affinity and selectivity for δ opioid binding sites. Proc. Natl. Acad. Sci. USA. 86:1989;5188-5192.
6. 3H ]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: Evidence for delta opioid receptor heterogeneity J. Pharmacol. Exp. Ther. 268:1994;836-846.
7. Fowler C.J., Fraser G.L. μ-, δ-, κ-Opioid receptors and their subtypes: A critical review with emphasis on radioligand binding experiments. Neurochem. Int. 24:1994;401-426.
8. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12:1957;12-15.
9. Hammond D.H., Stewart P.E., Littell L. Antinociception and δ-1 opioid receptors in the rat spinal cord: Studies with intrathecal 7-benzylidenenaltrexone. J. Pharmacol. Exp. Ther. 274:1995;1317-1324.
10. Hiller J.M., Itzhak Y., Simon E.J. Selective changes in mu, delta, and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients. Brain Res. 106:1987;17-23.
11. Itoh J., Nabeshima T., Kameyama T. Utility of an elevated plus-maze for the evaluation of memory in mice: Effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology. 101:1990;27-33.
12. Itoh J., Ukai M., Kameyama T. Dynorphin A-(1-13) markedly improves scopolamine-induced impairment of spontaneous alternation performance in mice. Eur. J. Pharmacol. 236:1993;341-345.
13. Itoh J., Ukai M., Kameyama T. Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the μ-selective opioid receptor agonist DAMGO in mice. J. Pharmacol. Exp. Ther. 269:1994;15-21.
14. Izquierdo I. Effect of β-endorphin and naloxone on acquisition, memory, and retrieval of shuttle avoidance and habituation learning in rats. Psychopharmacology. 69:1980;111-115.
15. 6]enkephalin and naltrindole 5′-isothiocyanate: Evidence for delta-receptor subtypes. J. Pharmacol. Exp. Ther. 257:1991;1069-1075.
16. Kameyama T., Nabeshima T., Kozawa T. Step-down-type passive avoidance- and escape-learning method suitability for experimental amnesia models. J. Pharmacol. Methods. 16:1986;39-52.
17. Martin W.R. Pharmacology of opioids. Pharmacol. Rev. 35:1984;283-323.
18. Martinez J.L. Jr., Rigter H. Endorphins after acquisition and consolidation of an inhibitory avoidance response in rats. Neurosci. Lett. 19:1980;197-201.
19. Mosberg H.I., Hurst R., Hurby V.J., Gee K., Yamamura H.I., Galligan J.J., Burks T.F. Bis-penicillamine enkephalins possess highly improved specificity towards delta opioid receptors. Proc. Natl. Acad. Sci. USA. 80:1983;5871-5874.
20. Mulder A.H., Wardeh G., Hogenboom F., Frankhuyzen A.L. κ- and δ-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature. 308:1984;278-280.
21. Parada-Turska J., Turski W.A. Excitatory amino acid antagonists and memory: Effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks. Neuropharmacology. 29:1990;1111-1116.
22. Pasternak G.W. Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. 16:1993;1-18.
23. Paterson S.J., Robson L.E., Kosterlitz H.W. Classification of opioid receptors. Br. Med. Bull. 39:1983;25-30.
24. 1-opioid receptor antagonist: 7-Benzylidenenaltrexone. Eur. J. Pharmacol. 218:1992;195-196.
25. Rady J.J., Takemori A.E., Portoghese P.S., Fujimoto J.M. Supraspinal delta receptor subtype activity of heroin and 6-monoacetylmorphine in Swiss Webster mice. Life Sci. 55:1994;603-609.
26. Sarter M., Bodewitz G., Stephens D.N. Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and agonist β-carbolines. Psychopharmacology. 94:1988;491-495.
27. Schulteis G., Martinez J.L. Jr., Hruby V.J. Stimulation and antagonism of opioid δ-receptors produce opposite effects on active avoidance conditioning in mice. Behav. Neurosci. 102:1988;678-686.
28. Sofuoglu M., Portoghese P.S., Takemori A.E. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes. J. Pharmacol. Exp. Ther. 257:1991;676-680.
29. Stahl, S.M., 1996. Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Cambridge University Press, Cambridge.
30. Takemori A.E., Portoghese P.S. The mixed antinociceptive agonist-antagonist activity of β-endorphin (1-27) in mice. Life Sci. 53:1993;1049-1052.
31. Tjon G.H.K., De Vries T.J., Nestby P., Wardeh G., Mulder A.H., Schoffelmeer A.N.M. Intermittent and chronic treatment induces long-lasting changes in δ-opioid receptor-regulated acetylcholine release in rat striatum and nucleus accumbens. Eur. J. Pharmacol. 283:1995;169-176.
32. Ukai M., Kobayashi T., Kameyama T. Dynorphin A-(1-13) attenuates basal forebrain-lesion-induced amnesia in rats. Brain Res. 625:1993;355-356.
33. Ukai M., Kobayashi T., Shinkai N., Shan-Wu X., Kameyama T. Dynorphin A-(1-13) potently improves scopolamine-induced impairment of passive avoidance response in mice. Eur. J. Pharmacol. 274:1995;89-93.
34. Ukai M., Shinkai N., Kameyama T. κ-Opioid receptor agonists improve pirenzepine-induced disturbance of spontaneous alternation performance in the mouse. Eur. J. Pharmacol. 281:1995;173-178.
35. 2, a novel dermorphin analog, with high affinity for μ-opioid receptors. Eur. J. Pharmacol. 287:1995;245-249.
36. Walker D.L., McGlynn T., Grey C., Ragozzino M., Gold P.E. Naloxone modulates the behavioral effects of cholinergic agonists and antagonists. Psychopharmacology. 105:1991;57-62.
37. Wüster M., Schulz R., Herz A. Multiple opiate receptors in peripheral tissue preparations. Biochem. Pharmacol. 30:1981;1883-1887.